CStone Pharmaceuticals Reports 2023 Annual Results and Busin

SUZHOU, China, March 27, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research,

Related Keywords

China , United States , Thailand , United Kingdom , Singapore , London , City Of , Taiwan , Australia , Macau , Hong Kong , Suzhou , Jiangsu , Australian , American , British , Chinese , America , Les Laboratoires Servier , Jason Yang , National Medical Products Administration , Pfizer , Esmo Gi Congress , Chinese Medical Association , Cstone Pharmaceuticals , Research Pipeline Leveraging Multiple Sources Of Innovation , Chinese Society Of Clinical Oncology , International Financial Reporting Standards , Clinical Cancer Research , 3sbio Inc , Blueprint Medicines Corporation , European Medicines Agency , Australian Human Research Ethics Committee , Jiangsu Hengrui Pharmaceuticals Co Ltd , Drug Administration , Data Monitoring Committee , European Union , European Society For Medical Oncology , American Society Of Clinical Oncology , Committee For Medicinal Products Human Use , Allist Pharmaceuticals , Regulatory Agency , Pipeline Development , Contract Research Organization , American Society Of Hematology Annual Meeting , Cancer Association , Good Clinical Practice , Mainland China , American Society , Clinical Oncology , Annual Meeting , European Society , Medical Oncology , Gastrointestinal Cancer , Nature Medicine , Nature Cancer , Greater China , Drug Evaluation , Maximizing Commercial Value , National Reimbursement Drug List , National Basic Medical Insurance , Work Related Injury Insurance , Maternity Insurance , Systemic Mastocytosis , Anti Cancer Association , Hematological Oncology Guideline , Medical Association , Hematology Annual Meeting , Further Information , Outstanding Issues , Overall Survival , Combined Positive Score , British Journal , Taiwan Food , Blueprint Medicines , Clinical Cancer , Research Pipeline Leveraging Multiple Sources , License Agreement , Medicinal Products , Human Use , Financial Reporting Standards , Pharmaceuticals Reports , Thailand Business ,